MET director reports 534‑share purchase; ownership now 4,261

Rhea-AI Filing Summary

Laura J. Hay, a non‑management director of MetLife, Inc. (MET), reported a purchase of 534 shares of MetLife common stock on 10/01/2025 at a price of $81.93 per share. After the transaction, the reporting person beneficially owned 4,261 shares. The Form 4 notes these shares are part of the director retainer that the director elected to defer under the MetLife Deferred Compensation Plan for Non‑Management Directors. The filing was signed by an attorney‑in‑fact on 10/03/2025. The form contains no options or derivative transactions and no other changes to ownership were disclosed.

Positive

• Director purchased 534 shares, increasing alignment with shareholders
• Shares deferred under company plan, indicating use of standard compensation program
• Beneficial ownership of 4,261 shares reported, providing transparency

Negative

• None.

Insights

Insider Transactions Analyst

Director acquired 534 MetLife shares at $81.93 on 10/01/2025.

The reported purchase increases the director's direct holding to 4,261 shares, reflecting compensation payment converted to stock and deferred under the company's director deferred compensation plan.

This transaction is disclosed as compensation‑related rather than a discretionary market purchase, which is typical for non‑management director retainer arrangements and signals routine ownership accumulation consistent with board compensation policy.

Corporate Governance Specialist

Transaction arises from director retainer deferral; no derivatives or unusual dispositions.

The Form 4 explicitly states the shares are part of the non‑management director retainer and were deferred under the MetLife Deferred Compensation Plan for Non‑Management Directors, indicating this is a standard compensation settlement, not ad hoc trading.

Such filings confirm compliance with Section 16 reporting and provide transparency on director ownership levels; the filing contains no additional governance events.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Hay Laura J

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVE

(Street)

NEW YORK NY 10166

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A(1)		534	A	$81.93	4,261	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did MetLife director Laura J. Hay report (MET)?

The Form 4 reports a purchase of 534 shares on 10/01/2025 at $81.93 per share.

How many MetLife shares does the reporting person own after the reported transaction?

The reporting person beneficially owned 4,261 shares following the transaction.

Was the purchase part of a compensation or discretionary trade?

The filing states the shares derive from a non‑management director retainer and were deferred under the MetLife Deferred Compensation Plan for Non‑Management Directors.

Did the Form 4 disclose any derivative or option transactions?

No. Table II for derivative securities shows no transactions; only the non‑derivative stock purchase is reported.

When was the Form 4 signed and filed?

The signature block shows the form was signed by an attorney‑in‑fact on 10/03/2025.